The Cystic Fibrosis Foundation is giving Laurent Pharmaceuticals $2 million to conduct a Phase 2 clinical trial of Laurent’s cystic…
Articles by Patrícia Silva, PhD
Boston-based ProQr Therapeutics marked Rare Disease Day with an event commemorating one of its co-founders, rare disease pioneer Henri A. Termeer.
A company that provides remote monitoring of patients’ health conditions has created patient and caregiver advisory boards for the lung…
An Australian scientist has received a $1 million Cystic Fibrosis Foundation grant to study whether probiotics can improve the health and…
Anthera Pharmaceuticals has completed the last patient visit in the primary treatment phase of a Phase 3 clinical trial…
Motif Bio has received a $120,000 award from the Cystic Fibrosis Foundation (CFF) to fund in vitro testing of iclaprim…
Celtaxsys has obtained financing for a Phase 3 clinical trial of acebilustat as a treatment for cystic fibrosis. Acebilustat…
A possible inhalable treatment for antibiotic-resistant bacterial infections in people with cystic fibrosis due to Pseudomonas aeruginosa now has a U.S. patent…
Synspira received an award of up to $3 million from the Cystic Fibrosis Foundation to…
Arch Biopartners recently completed a good manufacturing practice (GMP) production campaign for AB569, a potential inhalation treatment for…